With the US Food and Drug Administration busier than ever with breakthrough and priority review designations, and the rise of genetic-based treatments offering new hope for patients and families, the pressure is on oncologists to push the limits in care. But if it costs $200,000 to extend life just a few weeks, does that make sense? Are doctors having that conversation? When they do, are patients hearing it? These are the very issues that will be on the table in Baltimore Nov. 14-15 when The American Journal of Managed Care convenes experts from the front line.
FOR IMMEDIATE RELEASE October 22, 2013
If $100G Cancer Drugs Worry You, Join Us!
‘Cancer Drug Racket’ Article, ‘Morning Joe’ Segment Draw Attention
to Debate Over Balancing Care, Cost in Oncology
Baltimore Meeting Nov. 14-15 to Bring Experts Together on How to Make Tough Calls
PLAINSBORO, N.J. — From the article in New York magazine that called some current therapies a “cancer drug racket,” to Dr. Zeke Emanuel’s appearance this week on MSNBC’s “Morning Joe,’ there is growing awareness of the tough decisions that doctors and health plan executives must make as both the breakthroughs and costs escalate in the world of cancer care.
With the US Food and Drug Administration busier than ever with “breakthrough” and “priority review” designations, and the rise of genetic-based treatments offering new hope for patients and families, the pressure is on oncologists to push the limits in care. But, as Emanuel explained on MSNBC, if it costs $200,000 to extend life just a few weeks, does that make sense? And, he explained further, are doctors having that conversation? When they do, are patients hearing it?
These are the very issues that will be on the table in Baltimore Nov. 14-15 when The American Journal of Managed Care convenes experts from the front lines — clinical and academic leaders, developers of life-saving therapies, and those who are transforming the way healthcare does business. For more information about the conference and a proposed agenda, please visit the web site at: http://www.ajmc.com/meetings/oncologycare13.
“Patient-Centered Oncology Care: Real World Perspectives” will take place November 14-15 at the Royal Sonesta Harbor Court, Baltimore. This two-day conference, which features an evening networking reception, will bring together key leaders in managed care and beyond. All will share how the goals of better care, savings and fair compensation can be achieved, even in the world of oncology.
Attend this conference if you want to know:
Credentialed media who wish to register for the conference must contact Nicole Beagin or Mary Caffrey at (609) 716-7777. A limited number of hotel rooms have been reserved, but members of the media must contact Nicole Beagin to hold a room at the conference rate.
Highlights on major speakers at the conference are attached.
CONTACT:
Nicole Beagin (609) 716-7777 x. 131
Mary Caffrey (609) 716-7777 x. 144
Follow us on @AJMC_Journal and @EBOncology
Mental Health Diagnoses, Care Challenges Rise Among US Youth, Report Finds
April 26th 2024While behavioral health care utilization has been rising, the treatment landscape has been falling. New findings show that 20% of youths did not receive any form of treatment within 3 months of their initial behavioral health diagnosis.
Read More
Examining Low-Value Cancer Care Trends Amidst the COVID-19 Pandemic
April 25th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the April 2024 issue of The American Journal of Managed Care® about their findings on the rates of low-value cancer care services throughout the COVID-19 pandemic.
Listen
Navigating Health Literacy, Social Determinants, and Discrimination in National Health Plans
February 13th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the February 2024 issue of The American Journal of Managed Care® about their findings on how health plans can screen for health literacy, social determinants of health, and perceived health care discrimination.
Listen
Dr Dalia Rotstein: Physicians Must Be Aware MS Affects People of All Backgrounds
April 24th 2024Dalia Rotstein, MD, MPH, emphazises the importance of awareness that multiple sclerosis (MS) impacts patients from various backgrounds as clinicians think through ways to improve access to care and research efforts in MS.
Read More